Outset Medical (OM) Cash & Equivalents (2019 - 2026)

Outset Medical (OM) has 8 years of Cash & Equivalents data on file, last reported at $160.5 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 16.54% year-over-year to $160.5 million in Q1 2026; TTM through Mar 2026 was $160.5 million, a 16.54% decrease from a year earlier, with the FY2025 full-year figure at $35.0 million, down 71.77% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $160.5 million, up from $35.0 million in the prior quarter.
• Over the last five years, Cash & Equivalents for OM reached as high as $192.3 million in Q1 2025 and fell as low as $35.0 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $71.1 million across 5 years, with a median of $39.6 million in 2025.
• Across the five-year window, Cash & Equivalents tumbled 72.47% in 2022 and soared 441.61% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $76.5 million in 2022, then fell by 6.13% to $71.8 million in 2023, then soared by 72.63% to $124.0 million in 2024, then tumbled by 71.77% to $35.0 million in 2025, then surged by 358.49% to $160.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $160.5 million in Q1 2026, $35.0 million in Q4 2025, and $36.4 million in Q3 2025.